Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
- 18 September 2022
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 400 (10361), 1405-1416
- https://doi.org/10.1016/s0140-6736(22)01787-1
Abstract
No abstract availableKeywords
Funding Information
- Medtronic Inc
- Medtronic
This publication has 33 references indexed in Scilit:
- Reinnervation of Renal Afferent and Efferent Nerves at 5.5 and 11 Months After Catheter-Based Radiofrequency Renal Denervation In SheepHypertension, 2015
- Predictors of blood pressure response in the SYMPLICITY HTN-3 trialEuropean Heart Journal, 2014
- Non-adherence to cardiovascular medicationsEuropean Heart Journal, 2014
- Impact of Renal Denervation on 24-Hour Ambulatory Blood PressureJournal of Invasive Cardiology, 2014
- A Controlled Trial of Renal Denervation for Resistant HypertensionThe New England Journal of Medicine, 2014
- Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisEuropean Heart Journal, 2012
- Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 TrialClinical Cardiology, 2012
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort studyThe Lancet, 2009
- Analytical approaches to reporting long-term clinical trial dataCurrent Medical Research and Opinion, 2008
- Sham device v inert pill: randomised controlled trial of two placebo treatmentsBMJ, 2006